Projects per year
Fingerprint
Dive into the research topics where Kate Hyde is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 6 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
-
-
Analysis of Initiating Events in Inv(16) Associated Acute Myeloid Leukemia
9/20/13 → 8/31/16
Project: Research project
Research output
-
CHD7 and Runx1 interaction provides a braking mechanism for hematopoietic differentiation
Hsu, J., Huang, H. T., Lee, C. T., Choudhuri, A., Wilson, N. K., Abraham, B. J., Moignard, V., Kucinski, I., Yu, S., Hyde, R. K., Tober, J., Cai, X., Li, Y., Guo, Y., Yang, S., Superdock, M., Trompouki, E., Calero-Nieto, F. J., Alireza, G., Jiang, J. & 17 others, , Sep 22 2020, In: Proceedings of the National Academy of Sciences of the United States of America. 117, 38, p. 23626-23635 10 p.Research output: Contribution to journal › Article › peer-review
-
IL-33/IL1RL1 axis regulates cell survival through the p38 MAPK pathway in acute myeloid leukemia
Wang, Y., Luo, H., Wei, M., Becker, M., Hyde, R. K. & Gong, Q., Sep 2020, In: Leukemia Research. 96, 106409.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
RUNX1 and CBFb-SMMHC transactivate target genes together in abnormal myeloid progenitors for leukemia development
Zhen, T., Cao, Y., Ren, G., Zhao, L., Hyde, R. K., Lopez, G., Feng, D., Alemu, L., Zhao, K. & Paul Liu, P., Nov 19 2020, In: Blood. 136, 21, p. 2373-2385 13 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Use of polymeric CXCR4 inhibitors as siRNA delivery vehicles for the treatment of acute myeloid leukemia
Wang, Y., Xie, Y., Williams, J., Hang, Y., Richter, L., Becker, M., Amador, C., Oupický, D. & Hyde, R. K., Feb 1 2020, In: Cancer Gene Therapy. 27, 1-2, p. 45-55 11 p.Research output: Contribution to journal › Article › peer-review
5 Scopus citations -
HDAC1 is a required cofactor of CBFb-SMMHC and a potential therapeutic target in inversion 16 acute myeloid leukemia
Richter, L. E., Wang, Y., Becker, M. E., Coburn, R. A., Williams, J. T., Amador, C. & Hyde, R. K., Jun 1 2019, In: Molecular Cancer Research. 17, 6, p. 1241-1252 12 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations